$8.43
0.151.81%
At Close: -
$8.43
-0.0016-0.02%
After Hours: 4:34 PM EDT
15 minutes delayed
Comments
Loading...
Eliem Therapeutics (ELYM) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEliem Therapeutics (NASDAQ:ELYM) Stock Quotes, Forecast and News Summary
Eliem Therapeutics Stock (NASDAQ: ELYM) stock price, news, charts, stock research, profile.
| Open | $8.18 |
| Close | $8.43 |
| Volume / Avg. | 4.64M / 264.73K |
| Day Range | $7.94 - $8.57 |
| 52 Wk Range | 2.35 - 11.55 |
| Market Cap | $565.21M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 64 |
| Short Interest | 2.34% |
| Days to Cover | 3.8 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Eliem Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Eliem Therapeutics (ELYM) stock?
You can purchase shares of Eliem Therapeutics (NASDAQ:ELYM) through any online brokerage.
Who are Eliem Therapeutics (ELYM) competitors?
Other companies in Eliem Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
What is the forecast, or price target, for Eliem Therapeutics (ELYM) stock?
Eliem Therapeutics has a consensus price target of $5.00.
What is the current price for Eliem Therapeutics (ELYM)?
The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $8.4284 last updated September 20, 2024 at 4:34 PM EDT.
Does Eliem Therapeutics (ELYM) pay a dividend?
There are no upcoming dividends for Eliem Therapeutics.
When is Eliem Therapeutics (NASDAQ:ELYM) reporting earnings?
Eliem Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Eliem Therapeutics (ELYM) going to split?
There is no upcoming split for Eliem Therapeutics.
What sector and industry does Eliem Therapeutics (ELYM) operate in?
Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.